HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CT and MRI early vessel signs reflect clot composition in acute stroke.

AbstractBACKGROUND AND PURPOSE:
The purpose of this study was to provide the first correlative study of the hyperdense middle cerebral artery sign (HMCAS) and gradient-echo MRI blooming artifact (BA) with pathology of retrieved thrombi in acute ischemic stroke.
METHODS:
Noncontrast CT and gradient-echo MRI studies before mechanical thrombectomy in 50 consecutive cases of acute middle cerebral artery ischemic stroke were reviewed blinded to clinical and pathology data. Occlusions retrieved by thrombectomy underwent histopathologic analysis, including automated quantitative and qualitative rating of proportion composed of red blood cells (RBCs), white blood cells, and fibrin on microscopy of sectioned thrombi.
RESULTS:
Among 50 patients, mean age was 66 years and 48% were female. Mean (SD) proportion was 61% (±21) fibrin, 34% (±21) RBCs, and 4% (±2) white blood cells. Of retrieved clots, 22 (44%) were fibrin-dominant, 13 (26%) RBC-dominant, and 15 (30%) mixed. HMCAS was identified in 10 of 20 middle cerebral artery stroke cases with CT with mean Hounsfield Unit density of 61 (±8 SD). BA occurred in 17 of 32 with gradient-echo MRI. HMCAS was more commonly seen with RBC-dominant and mixed than fibrin-dominant clots (100% versus 67% versus 20%, P=0.016). Mean percent RBC composition was higher in clots associated with HMCAS (47% versus 22%, P=0.016). BA was more common in RBC-dominant and mixed clots compared with fibrin-dominant clots (100% versus 63% versus 25%, P=0.002). Mean percent RBC was greater with BA (42% versus 23%, P=0.011).
CONCLUSIONS:
CT HMCAS and gradient-echo MRI BA reflect pathology of occlusive thrombus. RBC content determines appearance of HMCAS and BA, whereas absence of HMCAS or BA may indicate fibrin-predominant occlusive thrombi.
AuthorsDavid S Liebeskind, Nerses Sanossian, William H Yong, Sidney Starkman, Michael P Tsang, Antonio L Moya, David D Zheng, Anna M Abolian, Doojin Kim, Latisha K Ali, Samir H Shah, Amytis Towfighi, Bruce Ovbiagele, Chelsea S Kidwell, Satoshi Tateshima, Reza Jahan, Gary R Duckwiler, Fernando Viñuela, Noriko Salamon, J Pablo Villablanca, Harry V Vinters, Victor J Marder, Jeffrey L Saver
JournalStroke (Stroke) Vol. 42 Issue 5 Pg. 1237-43 (May 2011) ISSN: 1524-4628 [Electronic] United States
PMID21393591 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Fibrin
Topics
  • Aged
  • Aged, 80 and over
  • Artifacts
  • Blood Platelets (diagnostic imaging, pathology)
  • Erythrocytes (diagnostic imaging, pathology)
  • Female
  • Fibrin (ultrastructure)
  • Humans
  • Infarction, Middle Cerebral Artery (diagnostic imaging, pathology)
  • Leukocytes (diagnostic imaging, pathology)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Retrospective Studies
  • Stroke (diagnostic imaging, pathology)
  • Thrombectomy
  • Thrombosis (diagnostic imaging, pathology)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: